OEMINE ARTRO HARPAGOPHYTUM CASSIS
Food supplement declared in France, declaration No 2023-1-1481, decision dated 27 January 2023
OEMINE ARTRO HARPAGOPHYTUM CASSIS, from PHYBIO PHARMA, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 960 mg per day, Ribes nigrum 270 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- OEMINE
- Food business operator placing the product on the market
- PHYBIO PHARMA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- 1 gélule matin midi et soir
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
Declaration 308646, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Organes souterrains | Extrait sec aqueux | 960 mg |
| Ribes nigrum L. | Feuille | Extrait sec aqueux | 270 mg |
Additives
E551, E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ce complément alimentaire ne doit pas être pris pendant la grossesse ni l'allaitement, ni par des personnes sousanti-inflammatoires ou anti-vitamine K. En cas de prise d'autres médicaments, demandez conseil à votre médecin ou àvotre pharmacien.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : OEMINE
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “OEMINE ARTRO HARPAGOPHYTUM CASSIS: composition and regulation”, https://compoatlas.com/en/supplements/products/308646-oemine-artro-harpagophytum-cassis, updated 15 November 2026.